One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Accesshttps://doi.org/10.1182/blood.v130.suppl_1.4042.4042
Copy DOI Journal: Blood |  Publication Date: Jun 25, 2021 |
Affiliation: University of Bologna, South Texas Accelerated Research Therapeutics, Hôpital Claude Huriez, Université de Lyon, Hospices Civils de Lyon, Humanitas University, Hôpital Maisonneuve-Rosemont, University of Bordeaux, Royal Marsden Hospital, Helsinki University Hospital, Cambridge University Hospitals NHS Foundation Trust, Bayer (United States), Bayer (Germany), LMU KlinikumPooled Safety Analysis from Phase I and II Studies for Patients with Relapsed Indolent Non-Hodgkin's Lymphoma Treated with Intravenous Copanlisib
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
